Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welcoxia 90 Etoricoxib Tablets 60 mg
Welcoxia 90 is a next-generation NSAID designed to provide powerful pain relief with reduced gastrointestinal risks. It contains Etoricoxib, a selective COX-2 inhibitor, which effectively reduces inflammation, swelling, and pain in various musculoskeletal and acute pain conditions.
Uses of Welcoxia 90 Etoricoxib Tablets 60 mg
Management of osteoarthritis and rheumatoid arthritis
Relief from ankylosing spondylitis and gout-related pain
Treatment of acute musculoskeletal pain and post-surgical inflammation
Pain control in dental and minor surgical procedures
Benefits of Welcoxia 90 Etoricoxib Tablets 60 mg
Targeted COX-2 inhibition for effective pain relief
Lower risk of gastric ulcers compared to traditional NSAIDs
Long-lasting action requiring once-daily dosing
Clinically proven for chronic pain management
Mechanism of Action of Welcoxia 90 Etoricoxib Tablets 60 mg
Etoricoxib selectively inhibits the COX-2 enzyme, reducing the production of prostaglandins, which are responsible for pain and inflammation. This provides potent analgesic and anti-inflammatory effects while minimizing the gastrointestinal risks associated with non-selective NSAIDs.